Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Pitavastatin 2 mg Tablet vs Livalo 2 mg in Healthy Thai Volunteers (Fasting)
TCTR20200306002Phase 0Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of pitavastatin in hypercholesterolemia (2 arms), sponsored by Bio-innova. Primary endpoint: Primary pharmacokinetic bioequivalence parameters. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
pitavastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20200306002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200306002.